Back to top

NAMS forms MACD Bearish Centerline Cross on July 17

NewAmsterdam Pharma Company N.V. (NAMS) — Nightly Technical Analysis · Jul 17, 2026, 19:56 ET
NAMS finished higher by 2.03% on Friday, July 17th, trading 0.6 times its typical volume. MACD Bearish Centerline Cross was spotted, which could indicate a shift in momentum. Key support levels exist at 30.89, 30.1 & 29.51, with resistance at 32.28, 32.87 & 33.66. Slow Stochastic readings suggest the stock is currently oversold.

Current SwingTradeBot Technical Rating of NAMS: D

This might just be the start. See what else showed up for NAMS today.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NewAmsterdam Pharma Company N.V. (NAMS)